Filing Details
- Accession Number:
- 0001209191-17-065297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-12 20:14:39
- Reporting Period:
- 2017-12-08
- Accepted Time:
- 2017-12-12 20:14:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1609320 | Werner Kroll | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | Svp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-08 | 7,100 | $23.41 | 10,818 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-08 | 7,100 | $40.49 | 3,718 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-12-08 | 9,258 | $23.41 | 12,976 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-08 | 9,258 | $40.41 | 3,718 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option | Disposition | 2017-12-08 | 7,100 | $0.00 | 7,100 | $23.41 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2017-12-08 | 9,258 | $0.00 | 9,258 | $23.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,854 | 2017-02-05 | 2025-02-05 | No | 4 | M | Direct |
| 17,596 | 2017-02-05 | 2025-02-05 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $40.485564 per share, with a range of $40.40 to $40.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $40.406319 per share, with a range of $40.36 to $40.45. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
